3/27/2013 7:10:46 AM
Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter and fiscal year ended December 31, 2012.
Fourth Quarter and Fiscal Year 2012 Financial Results:
Total operating expenses for the fourth quarter ended December 31, 2012 were $8.1 million, as compared to $11.1 million for the third quarter ended September 30, 2012.
comments powered by